| Patents for A61P 21 - Drugs for disorders of the muscular or neuromuscular system (23,287) |
|---|
| 05/04/2005 | EP1527068A2 Novel arylimidazole derivatives, preparation and therapeutic uses thereof |
| 05/04/2005 | EP1527051A1 Pyrimidyl sulphone amide derivatives as chemokine receptor modulators |
| 05/04/2005 | EP1526895A2 Methods for treating carbonic anhydrase mediated disorders |
| 05/04/2005 | EP1526869A1 Compositions of a cyclooxygenase-2 selective inhibitor and a carbonic anhydrase inhibitor for the treatment of neoplasia |
| 05/04/2005 | EP1526847A2 Pharmaceutical dosage form comprising a sulfite compound |
| 05/04/2005 | EP1526846A2 Gelatin capsule exhibiting reduced cross-linking |
| 05/04/2005 | EP1526845A2 Pharmaceutical dosage form capable of maintaining stable dissolution profile upon storage |
| 05/04/2005 | EP1526844A2 Pellicle-resistant gelatin capsule |
| 05/04/2005 | EP1448553B1 N-heterocyclyl hydrazides as neurotrophic agents |
| 05/04/2005 | EP1395582B1 Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same |
| 05/04/2005 | EP1259477B1 Aminoadamantane derivatives as therapeutic agents |
| 05/04/2005 | CN1612745A Methods for slowing senescence and treating and preventing diseases associated with senescence |
| 05/04/2005 | CN1611499A Heterocyclic compounds as inhibitors of rotamase enzymes |
| 05/04/2005 | CN1199974C Spiro (2H-1-benzopyran-2,4'-piperididine) derivates as glycine transport inhibitors |
| 05/04/2005 | CN1199954C Benzodiazepine derivatives |
| 05/04/2005 | CN1199950C Quinolene derivatives as anti-inflammation agents |
| 05/04/2005 | CN1199656C Medicine for treating myasthenia gravis |
| 05/03/2005 | US6887996 Compounds and their use |
| 05/03/2005 | US6887891 Derivatives of lipoic acid, their preparation, their use as medicaments and the pharmaceutical compositions containing them |
| 05/03/2005 | US6887872 Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same |
| 05/03/2005 | US6887865 N-heterocyclic derivatives as NOS inhibitors |
| 05/03/2005 | US6887844 To stimulate the proliferation or/and the outgrowth from cells presenting the neural cell adhesion molecule (NCAM) |
| 05/03/2005 | US6887462 For diagnosis, prevention, or treatment of diseases responsive to therapy with interferon- beta (IFN-beata) |
| 04/28/2005 | WO2005036989A1 Health food containing hyaluronic acid and dermatan sulfate |
| 04/28/2005 | WO2003099201A3 Compositions and methods of use for a fibroblast growth factor |
| 04/28/2005 | WO2003044170A3 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use |
| 04/28/2005 | US20050090547 Combinations of retigabine and sodium channel inhibitors or sodium channel-influencing active compounds for treating pains |
| 04/28/2005 | US20050090517 Pharmaceutical combinations of cox-2 inhibitors and opiates |
| 04/28/2005 | US20050090491 2'-Methyl-5'-(1,3,4-oxadiazol-2-yl)-1,1'-biphenyl-4-carboxamide derivatives and their use as p38 kinase inhibitors |
| 04/28/2005 | US20050090487 Cardiovascular disorders; antiinflammatory agents |
| 04/28/2005 | US20050089933 Compositions and methods for surrogate antibody modulation of an immune response and transport |
| 04/28/2005 | US20050089911 87 human secreted proteins |
| 04/28/2005 | US20050089559 Flupirtine in combination with tolperisone or its analogs, such as eperisone or silperisone; pains which are accompanied by an increase in muscle tone such as neuralgia |
| 04/28/2005 | US20050089479 Delivery of sedative-hypnotics through an inhalation route |
| 04/28/2005 | CA2543406A1 Mutants of human chondromodulin-i (hchm-i) and uses thereof in inhibiting angiogenesis and bone resorption |
| 04/28/2005 | CA2542433A1 Use of growth hormone releasing factor analogs in treating patients suffering from wasting |
| 04/28/2005 | CA2542290A1 Substituted 2-amino-[1,2,4]triazolo[1,5-a]pyrimidine derivative and use thereof |
| 04/27/2005 | EP1526141A2 MHC complexes and uses thereof |
| 04/27/2005 | EP1526136A1 Polymorphs of zaleplon and methods for the preparation thereof |
| 04/27/2005 | EP1526130A1 Substituted isoquinolines as ultra short acting neuromuscular blockers |
| 04/27/2005 | EP1525883A1 Ciclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect |
| 04/27/2005 | EP1525200A1 2-(3-aminoaryl)amino-4-aryl-thiazoles and their use as c-kit inhibitors |
| 04/27/2005 | EP1525000A2 Gastrointestinal delivery of genetic material coupled to a transporting agent |
| 04/27/2005 | EP1524997A1 Stable liquid parenteral parecoxib formulation |
| 04/27/2005 | EP1419150B1 Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use |
| 04/27/2005 | EP1289519A4 Methods of treating androgen deficiency in men using selective antiestrogens |
| 04/27/2005 | EP1261327B1 Adenosine receptor modulators |
| 04/27/2005 | EP1253932B1 Botulinum toxin pharmaceutical compositions |
| 04/27/2005 | EP0994853B1 A monoether of probucol and methods for the inhibition of the expression of vcam-1 |
| 04/27/2005 | CN1610682A Polymorphs of zaleplon and methods for the preparation thereof |
| 04/27/2005 | CN1610674A Use of 2-amino-thiazoline derivatives as inhibitors of inducible NO-synthase |
| 04/27/2005 | CN1610671A Quinoline compounds with 5-HT-antagonistic properties for therapy |
| 04/27/2005 | CN1610542A New use for the treatment of gastroesophageal reflux disease |
| 04/27/2005 | CN1608513A Health food containing hyaluronic acid and dermatan sulfate |
| 04/27/2005 | CN1198841C Method for preparing cyclic vasoactive peptide analogs |
| 04/27/2005 | CN1198824C Polymorphs of N-methyl-N-(3-3-{2-thienylcarbonyl]-pyrazol -[1,5-alpha]-pyrimidin-7-yl}phenyl)a cetamide and compositions and methods related thereton |
| 04/27/2005 | CN1198818C Compound with growth hormone releasing properties |
| 04/27/2005 | CN1198622C Steroidal saponins for treating alzheimer's disease and derivatives thereof |
| 04/27/2005 | CN1198618C Novel use of 1-[4-(5-cyanoindol-3-yl)butyl]-4-(2-carbamoyl-benzofuran-5-yl)-piperazine and its physiologically acceptable salts |
| 04/27/2005 | CN1198613C Aminophenoxyacetic acid derivatives and pharmaceutical composition containing the same |
| 04/27/2005 | CN1198589C Method for controlling liposome size |
| 04/26/2005 | US6884805 Polymorph forms of N-(2,3-dimethyl-5,6,7,8-tetrahydrofuro[2,3-B]quinolin-4-YL)-2-(2-oxopyrrolidin-1-YL)acetamide |
| 04/26/2005 | US6884785 Compositions and methods for the treatment or prevention of autoimmune diabetes |
| 04/26/2005 | US6884413 Immunosuppressants for organ transplantions by inducing apoptosis/anergy in T cells; genetic engineering; antigen presenting cells |
| 04/26/2005 | US6884408 Delivery of diphenhydramine through an inhalation route |
| 04/21/2005 | WO2005035536A1 Novel xanthone derivative, process for producing the same and pharmaceutical composition containing the same |
| 04/21/2005 | WO2005034965A1 Use of hyaluronic acid for treating sprain and strain |
| 04/21/2005 | WO2004108119A3 Use of atp or derivatives in medicine |
| 04/21/2005 | WO2004005313A3 Hybrid molecules of macrolides with steroid/non-steroid anti-inflammatory, antineoplastic and antiviral active molecules |
| 04/21/2005 | US20050085519 Controlling cell differentiation, cell proliferation; anticancer agents |
| 04/21/2005 | US20050085514 Psychological disorders; schizophrenia; anxiolytic agents; antidepressants; bipolar diseases; circadian rhythm disorders; analgesics; Parkinson's disease; Huntington's disease |
| 04/21/2005 | US20050085457 Therapeutic quinolone compounds with 5-ht-antagonistic properties |
| 04/21/2005 | US20050084518 For producing beautiful skin and improving constipation, reducing hair loss |
| 04/21/2005 | US20050084463 Antiinflammatory, antiarthritic agents, analgesics for pain caused by diabetic assoicated conditions, pneumoconiosis, angina, menstruation or cancer |
| 04/20/2005 | EP1523556A1 Methods of treating conditions associated with an edg-1 receptor |
| 04/20/2005 | EP1523323A2 Reagents and methods for smooth muscle therapies |
| 04/20/2005 | EP1523321A1 Use of ginkgo biloba extracts in order to promote muscle mass to the detriment of fatty mass |
| 04/20/2005 | EP1252158B1 Nicotinamide benzofused-heterocyclyl derivatives useful as selective inhibitors of pde4 isozymes |
| 04/20/2005 | EP1226110B1 Bicyclic amino acids as pharmaceutical agents |
| 04/20/2005 | EP1185649B1 The myostatin gene promoter and inhibition of activation thereof |
| 04/20/2005 | CN1608067A Pyrrolopyrimidines as phosphodiesterase vii inhibitors |
| 04/20/2005 | CN1608061A Therapeutic isoquinoline compounds |
| 04/20/2005 | CN1608054A Therapeutic quinolone compounds with 5-HT-antagonistic properties |
| 04/20/2005 | CN1607960A Glycoprotein compositions |
| 04/20/2005 | CN1607959A Human polypeptides causing or leading to the killing of cells including lymphoid tumor cells |
| 04/20/2005 | CN1607952A Pharmaceutical compositions comprising a multifunctional phosphodiesterase inhibitor and an adenosine uptake inhibitor |
| 04/20/2005 | CN1607005A Soluble lymphotoxin- beta receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological disease |
| 04/19/2005 | US6881734 Pharmaceutical composition for the treatment of CNS and other disorders |
| 04/19/2005 | US6881730 Steroid compounds with a c17-alkyl side chain and an aromatic a-ring for use in therapy |
| 04/14/2005 | WO2005033123A1 Stable vitamin b6 derivative |
| 04/14/2005 | WO2005032562A1 Methods for treating acute and overuse sprain and strain using hyaluronic acid |
| 04/14/2005 | WO2005032517A1 Buccal, polar and non-polar spray containing diazepam |
| 04/14/2005 | WO2004108157B1 Use of myostatin (gdf8) inhibitors in conjunction with corticosteroids for treating neuromuscular disorders |
| 04/14/2005 | WO2003027228A3 Receptors and membrane-associated proteins |
| 04/14/2005 | US20050080257 Benzo'fisoindole derivatives with affinity to the ep4 receptor |
| 04/14/2005 | US20050080096 Condensed heterocyclic compounds |
| 04/14/2005 | US20050080037 Methods for treating acute and overuse sprain and strain using hyaluronic acid |
| 04/14/2005 | US20050080029 Administering to the cell the compound to be delivered, an organic halide, and/or a carrier; ultrasound may also be applied |
| 04/14/2005 | US20050080010 Suppression of immune response via inhibition of cathepsin S |
| 04/14/2005 | US20050079136 Therapy for pain, appetite inttensifiers, multiple sclerosis and asthma; drug delivery |